legislation: 115-s-3754
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115-s-3754 | 115 | s | 3754 | CURE High Drug Prices Act | Health | 2018-12-13 | 2018-12-13 | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | Senate | Sen. Blumenthal, Richard [D-CT] | CT | D | B001277 | 3 | Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act This bill prohibits price gouging by manufacturers of certain prescription drugs that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed. | 2023-01-11T13:40:40Z |